212.54
0.02%
-0.05
Pre-market:
211.30
-1.24
-0.58%
CME Group Inc stock is currently priced at $212.54, with a 24-hour trading volume of 1.98M.
It has seen a -0.02% decreased in the last 24 hours and a -1.23% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $212.8 pivot point. If it approaches the $208.9 support level, significant changes may occur.
Previous Close:
$212.59
Open:
$212.345
24h Volume:
1.98M
Market Cap:
$76.52B
Revenue:
$5.58B
Net Income/Loss:
$3.23B
P/E Ratio:
25.36
EPS:
8.38
Net Cash Flow:
$3.38B
1W Performance:
+1.38%
1M Performance:
-1.23%
6M Performance:
-0.72%
1Y Performance:
+13.18%
CME Group Inc Stock (CME) Company Profile
Name
CME Group Inc
Sector
Phone
312-930-1000
Address
20 South Wacker Drive, Chicago, IL
CME Group Inc Stock (CME) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-08-24 | Downgrade | Barclays | Overweight → Equal Weight |
Jan-03-24 | Downgrade | Goldman | Neutral → Sell |
Sep-06-23 | Upgrade | BofA Securities | Underperform → Neutral |
Jun-28-23 | Initiated | Barclays | Overweight |
Jan-05-23 | Upgrade | Credit Suisse | Neutral → Outperform |
Oct-12-22 | Initiated | Citigroup | Buy |
Oct-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
Aug-17-22 | Initiated | Rosenblatt | Sell |
Aug-15-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jun-10-22 | Upgrade | Atlantic Equities | Neutral → Overweight |
May-25-22 | Upgrade | Oppenheimer | Perform → Outperform |
May-16-22 | Downgrade | Argus | Buy → Hold |
Feb-15-22 | Initiated | Credit Suisse | Neutral |
Feb-10-22 | Reiterated | BofA Securities | Underperform |
Feb-10-22 | Reiterated | Citigroup | Buy |
Feb-10-22 | Reiterated | Compass Point | Neutral |
Feb-10-22 | Reiterated | Deutsche Bank | Hold |
Feb-10-22 | Reiterated | JP Morgan | Neutral |
Feb-08-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
Jan-20-22 | Upgrade | Rosenblatt | Sell → Neutral |
Dec-16-21 | Initiated | BofA Securities | Underperform |
Sep-14-21 | Upgrade | Atlantic Equities | Neutral → Overweight |
Jun-25-21 | Resumed | Credit Suisse | Neutral |
Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
Jun-10-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
Apr-30-21 | Downgrade | Argus | Buy → Hold |
Mar-24-21 | Upgrade | BofA Securities | Neutral → Buy |
Mar-01-21 | Upgrade | Keefe Bruyette | Underperform → Mkt Perform |
Feb-25-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jan-15-21 | Downgrade | Oppenheimer | Outperform → Perform |
Jan-08-21 | Downgrade | Deutsche Bank | Buy → Hold |
Jan-07-21 | Upgrade | JP Morgan | Underweight → Neutral |
Sep-23-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
Sep-11-20 | Initiated | Loop Capital | Sell |
Apr-14-20 | Downgrade | Keefe Bruyette | Mkt Perform → Underperform |
Mar-30-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Feb-26-20 | Upgrade | UBS | Neutral → Buy |
Jan-10-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
Dec-16-19 | Initiated | Credit Suisse | Neutral |
Sep-19-19 | Downgrade | Berenberg | Buy → Hold |
Sep-17-19 | Initiated | Oppenheimer | Outperform |
Apr-18-19 | Downgrade | Rosenblatt | Neutral → Sell |
Feb-15-19 | Downgrade | JP Morgan | Neutral → Underweight |
Jan-11-19 | Downgrade | BofA/Merrill | Buy → Neutral |
Dec-04-18 | Resumed | Barclays | Overweight |
Nov-28-18 | Initiated | Atlantic Equities | Neutral |
Nov-28-18 | Downgrade | UBS | Buy → Neutral |
Nov-20-18 | Upgrade | Berenberg | Hold → Buy |
Nov-20-18 | Resumed | Citigroup | Buy |
Nov-05-18 | Resumed | BofA/Merrill | Buy |
Jul-10-18 | Initiated | Compass Point | Neutral |
Apr-10-18 | Initiated | Bernstein | Outperform |
View All
CME Group Inc Stock (CME) Latest News
Nasdaq's (NDAQ) Q1 Earnings Miss, Revenues Top, Dividend Raised
Zacks Investment Research
Deep Dive Into CME Gr Stock: Analyst Perspectives (7 Ratings)
Benzinga
Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?
Benzinga
CME Group (CME) Q1 Earnings Top Estimates, Revenues Rise Y/Y
Zacks Investment Research
CME (CME) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research
Cracking the Code: 5 Reasons a Choppy Market Looms
Zacks Investment Research
CME Group Inc Stock (CME) Financials Data
CME Group Inc (CME) Revenue 2024
CME reported a revenue (TTM) of $5.58 billion for the quarter ending December 31, 2023, a +11.15% rise year-over-year.
CME Group Inc (CME) Net Income 2024
CME net income (TTM) was $3.23 billion for the quarter ending December 31, 2023, a +19.89% increase year-over-year.
CME Group Inc (CME) Cash Flow 2024
CME recorded a free cash flow (TTM) of $3.38 billion for the quarter ending December 31, 2023, a +13.86% increase year-over-year.
CME Group Inc (CME) Earnings per Share 2024
CME earnings per share (TTM) was $8.87 for the quarter ending December 31, 2023, a +20.03% growth year-over-year.
CME Group Inc Stock (CME) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
SHEPARD WILLIAM R | Director |
Mar 26 '24 |
Buy |
214.71 |
282 |
60,561 |
253,343 |
SHEPARD WILLIAM R | Director |
Mar 26 '24 |
Buy |
214.71 |
12 |
2,670 |
2,334 |
McCourt Timothy Francis | Sr MD Global Head Equity & FX |
Jan 31 '24 |
Sale |
206.78 |
35 |
7,237 |
6,447 |
SHEPARD WILLIAM R | Director |
Jan 18 '24 |
Buy |
202.44 |
1,331 |
269,488 |
253,060 |
SHEPARD WILLIAM R | Director |
Jan 18 '24 |
Buy |
202.44 |
59 |
11,880 |
2,322 |
SHEPARD WILLIAM R | Director |
Dec 28 '23 |
Buy |
210.79 |
266 |
56,170 |
251,729 |
SHEPARD WILLIAM R | Director |
Dec 28 '23 |
Buy |
210.79 |
12 |
2,476 |
2,263 |
Durkin Bryan T | Director |
Dec 11 '23 |
Sale |
216.37 |
5,560 |
1,203,018 |
62,452 |
Sammann Derek | Sr MD Gl Hd Commodity & Option |
Dec 04 '23 |
Sale |
222.07 |
1,862 |
413,494 |
0 |
Sammann Derek | Sr MD Gl Hd Commodity & Option |
Dec 01 '23 |
Sale |
220.50 |
10,681 |
2,355,165 |
1,862 |
About CME Group Inc
CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals. The company executes trade through its electronic trading platforms, open outcry, and privately negotiated transactions, as well as provides hosting, connectivity, and customer support for electronic trading through its co-location services. It also provides clearing and settlement services for exchange-traded contracts, as well as for cleared swaps; and regulatory reporting solutions for market participants through its repository services in the United States, the United Kingdom, Canada, and Australia. In addition, the company offers a range of market data services, including live quotes, delayed quotes, market reports, and historical data services, as well as index services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Cap:
|
Volume (24h):